Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 390

1.

Distinct roles of interferon alpha and beta in controlling chikungunya virus replication and modulating neutrophil-mediated inflammation.

Cook LE, Locke MC, Young AR, Monte K, Hedberg ML, Shimak RM, Sheehan KCF, Veis DJ, Diamond MS, Lenschow DJ.

J Virol. 2019 Oct 16. pii: JVI.00841-19. doi: 10.1128/JVI.00841-19. [Epub ahead of print]

PMID:
31619554
2.

Zika virus causes acute and chronic prostatitis in mice and macaques.

Halabi J, Jagger BW, Salazar V, Winkler ES, White JP, Humphrey PA, Hirsch AJ, Streblow DN, Diamond MS, Moley K.

J Infect Dis. 2019 Oct 16. pii: jiz533. doi: 10.1093/infdis/jiz533. [Epub ahead of print]

PMID:
31616920
3.

Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity.

Riedl W, Acharya D, Lee JH, Liu G, Serman T, Chiang C, Chan YK, Diamond MS, Gack MU.

Cell Host Microbe. 2019 Oct 9;26(4):493-503.e6. doi: 10.1016/j.chom.2019.09.012.

PMID:
31600501
4.

Clearance of Chikungunya virus infection in lymphoid tissues is promoted by treatment with an agonistic anti-CD137 antibody.

Hong JP, McCarthy MK, Davenport BJ, Morrison TE, Diamond MS.

J Virol. 2019 Oct 2. pii: JVI.01231-19. doi: 10.1128/JVI.01231-19. [Epub ahead of print]

PMID:
31578287
5.

Mechanisms of Pathogen Invasion into the Central Nervous System.

Cain MD, Salimi H, Diamond MS, Klein RS.

Neuron. 2019 Sep 4;103(5):771-783. doi: 10.1016/j.neuron.2019.07.015. Review.

PMID:
31487528
6.

Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and Drosophila.

Zhang R, Earnest JT, Kim AS, Winkler ES, Desai P, Adams LJ, Hu G, Bullock C, Gold B, Cherry S, Diamond MS.

Cell Rep. 2019 Sep 3;28(10):2647-2658.e5. doi: 10.1016/j.celrep.2019.07.105.

7.

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.

Hassan AO, Dmitriev IP, Kashentseva EA, Zhao H, Brough DE, Fremont DH, Curiel DT, Diamond MS.

Cell Rep. 2019 Sep 3;28(10):2634-2646.e4. doi: 10.1016/j.celrep.2019.08.005.

8.

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.

Slon-Campos JL, Dejnirattisai W, Jagger BW, López-Camacho C, Wongwiwat W, Durnell LA, Winkler ES, Chen RE, Reyes-Sandoval A, Rey FA, Diamond MS, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2019 Oct;20(10):1291-1298. doi: 10.1038/s41590-019-0477-z. Epub 2019 Sep 2.

PMID:
31477918
9.

Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA.

Young AR, Locke MC, Cook LE, Hiller BE, Zhang R, Hedberg ML, Monte KJ, Veis DJ, Diamond MS, Lenschow DJ.

PLoS Pathog. 2019 Aug 29;15(8):e1007993. doi: 10.1371/journal.ppat.1007993. eCollection 2019 Aug.

10.

Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity.

Earnest JT, Basore K, Roy V, Bailey AL, Wang D, Alter G, Fremont DH, Diamond MS.

J Exp Med. 2019 Oct 7;216(10):2282-2301. doi: 10.1084/jem.20190736. Epub 2019 Jul 23.

PMID:
31337735
11.

Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.

Jagger BW, Dowd KA, Chen RE, Desai P, Foreman B, Burgomaster KE, Himansu S, Kong WP, Graham BS, Pierson TC, Diamond MS.

J Infect Dis. 2019 Oct 8;220(10):1577-1588. doi: 10.1093/infdis/jiz338.

PMID:
31260518
12.

No IL-18BP? Avoid HAV.

Diamond MS.

J Exp Med. 2019 Aug 5;216(8):1728-1729. doi: 10.1084/jem.20190841. Epub 2019 Jun 26.

PMID:
31243052
13.

Therapeutic efficacy of favipiravir against Bourbon virus in mice.

Bricker TL, Shafiuddin M, Gounder AP, Janowski AB, Zhao G, Williams GD, Jagger BW, Diamond MS, Bailey T, Kwon JH, Wang D, Boon ACM.

PLoS Pathog. 2019 Jun 13;15(6):e1007790. doi: 10.1371/journal.ppat.1007790. eCollection 2019 Jun.

14.

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.

Kose N, Fox JM, Sapparapu G, Bombardi R, Tennekoon RN, de Silva AD, Elbashir SM, Theisen MA, Humphris-Narayanan E, Ciaramella G, Himansu S, Diamond MS, Crowe JE Jr.

Sci Immunol. 2019 May 17;4(35). pii: eaaw6647. doi: 10.1126/sciimmunol.aaw6647.

PMID:
31101672
15.

Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor.

Basore K, Kim AS, Nelson CA, Zhang R, Smith BK, Uranga C, Vang L, Cheng M, Gross ML, Smith J, Diamond MS, Fremont DH.

Cell. 2019 Jun 13;177(7):1725-1737.e16. doi: 10.1016/j.cell.2019.04.006. Epub 2019 May 9.

PMID:
31080061
16.

Zika virus causes acute infection and inflammation in the ovary of mice without apparent defects in fertility.

Caine EA, Scheaffer SM, Broughton DE, Salazar V, Govero J, Poddar S, Osula A, Halabi J, Skaznik-Wikiel ME, Diamond MS, Moley KH.

J Infect Dis. 2019 May 7. pii: jiz239. doi: 10.1093/infdis/jiz239. [Epub ahead of print]

PMID:
31063544
17.

Shared and Distinct Functions of Type I and Type III Interferons.

Lazear HM, Schoggins JW, Diamond MS.

Immunity. 2019 Apr 16;50(4):907-923. doi: 10.1016/j.immuni.2019.03.025. Review.

PMID:
30995506
18.

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics.

Pezzi L, Reusken CB, Weaver SC, Drexler JF, Busch M, LaBeaud AD, Diamond MS, Vasilakis N, Drebot MA, Siqueira AM, Ribeiro GS, Kohl A, Lecuit M, Ng LFP, Gallian P, de Lamballerie X; GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group.

Antiviral Res. 2019 Jun;166:66-81. doi: 10.1016/j.antiviral.2019.03.009. Epub 2019 Mar 21. Review.

19.

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes.

Fox JM, Roy V, Gunn BM, Huang L, Edeling MA, Mack M, Fremont DH, Doranz BJ, Johnson S, Alter G, Diamond MS.

Sci Immunol. 2019 Feb 22;4(32). pii: eaav5062. doi: 10.1126/sciimmunol.aav5062.

20.

Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice.

Salazar V, Jagger BW, Mongkolsapaya J, Burgomaster KE, Dejnirattisai W, Winkler ES, Fernandez E, Nelson CA, Fremont DH, Pierson TC, Crowe JE Jr, Screaton GR, Diamond MS.

Cell Rep. 2019 Feb 5;26(6):1585-1597.e4. doi: 10.1016/j.celrep.2019.01.052.

21.

Interferon lambda protects the female reproductive tract against Zika virus infection.

Caine EA, Scheaffer SM, Arora N, Zaitsev K, Artyomov MN, Coyne CB, Moley KH, Diamond MS.

Nat Commun. 2019 Jan 17;10(1):280. doi: 10.1038/s41467-018-07993-2.

22.

Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.

Long F, Doyle M, Fernandez E, Miller AS, Klose T, Sevvana M, Bryan A, Davidson E, Doranz BJ, Kuhn RJ, Diamond MS, Crowe JE Jr, Rossmann MG.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1591-1596. doi: 10.1073/pnas.1815432116. Epub 2019 Jan 14.

23.

Immune responses at the maternal-fetal interface.

Ander SE, Diamond MS, Coyne CB.

Sci Immunol. 2019 Jan 11;4(31). pii: eaat6114. doi: 10.1126/sciimmunol.aat6114. Review.

24.

Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine.

Bullard BL, Corder BN, Gorman MJ, Diamond MS, Weaver EA.

Sci Rep. 2018 Dec 20;8(1):18017. doi: 10.1038/s41598-018-35755-z.

25.

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections.

VanBlargan LA, Himansu S, Foreman BM, Ebel GD, Pierson TC, Diamond MS.

Cell Rep. 2018 Dec 18;25(12):3382-3392.e3. doi: 10.1016/j.celrep.2018.11.082.

26.

Cryo-EM Structures of Eastern Equine Encephalitis Virus Reveal Mechanisms of Virus Disassembly and Antibody Neutralization.

Hasan SS, Sun C, Kim AS, Watanabe Y, Chen CL, Klose T, Buda G, Crispin M, Diamond MS, Klimstra WB, Rossmann MG.

Cell Rep. 2018 Dec 11;25(11):3136-3147.e5. doi: 10.1016/j.celrep.2018.11.067.

27.

A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.

Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE Jr, Pierson TC.

Nat Microbiol. 2019 Jan;4(1):71-77. doi: 10.1038/s41564-018-0283-7. Epub 2018 Nov 19.

28.

Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein.

Kim AS, Austin SK, Gardner CL, Zuiani A, Reed DS, Trobaugh DW, Sun C, Basore K, Williamson LE, Crowe JE Jr, Slifka MK, Fremont DH, Klimstra WB, Diamond MS.

Nat Microbiol. 2019 Jan;4(1):187-197. doi: 10.1038/s41564-018-0286-4. Epub 2018 Nov 19.

29.

Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.

Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S.

Cell Host Microbe. 2018 Nov 14;24(5):743-750.e5. doi: 10.1016/j.chom.2018.09.015.

PMID:
30439343
30.

WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Theisen DJ, Davidson JT 4th, Briseño CG, Gargaro M, Lauron EJ, Wang Q, Desai P, Durai V, Bagadia P, Brickner JR, Beatty WL, Virgin HW, Gillanders WE, Mosammaparast N, Diamond MS, Sibley LD, Yokoyama W, Schreiber RD, Murphy TL, Murphy KM.

Science. 2018 Nov 9;362(6415):694-699. doi: 10.1126/science.aat5030.

31.

Zika Virus Vaccine Development: Progress in the Face of New Challenges.

Diamond MS, Ledgerwood JE, Pierson TC.

Annu Rev Med. 2019 Jan 27;70:121-135. doi: 10.1146/annurev-med-040717-051127. Epub 2018 Nov 2.

PMID:
30388054
32.

Animal Models of Zika Virus Infection during Pregnancy.

Caine EA, Jagger BW, Diamond MS.

Viruses. 2018 Oct 31;10(11). pii: E598. doi: 10.3390/v10110598. Review.

33.

Intestinal Dysmotility Syndromes following Systemic Infection by Flaviviruses.

White JP, Xiong S, Malvin NP, Khoury-Hanold W, Heuckeroth RO, Stappenbeck TS, Diamond MS.

Cell. 2018 Nov 15;175(5):1198-1212.e12. doi: 10.1016/j.cell.2018.08.069. Epub 2018 Oct 4.

PMID:
30293866
34.

The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.

Weiss CM, Trobaugh DW, Sun C, Lucas TM, Diamond MS, Ryman KD, Klimstra WB.

mSphere. 2018 Sep 19;3(5). pii: e00209-18. doi: 10.1128/mSphere.00209-18.

35.

The emergence of Zika virus and its new clinical syndromes.

Pierson TC, Diamond MS.

Nature. 2018 Aug;560(7720):573-581. doi: 10.1038/s41586-018-0446-y. Epub 2018 Aug 29. Review.

PMID:
30158602
36.

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.

Lofano G, Gorman MJ, Yousif AS, Yu WH, Fox JM, Dugast AS, Ackerman ME, Suscovich TJ, Weiner J, Barouch D, Streeck H, Little S, Smith D, Richman D, Lauffenburger D, Walker BD, Diamond MS, Alter G.

Sci Immunol. 2018 Aug 17;3(26). pii: eaat7796. doi: 10.1126/sciimmunol.aat7796.

37.

Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy.

Regla-Nava JA, Elong Ngono A, Viramontes KM, Huynh AT, Wang YT, Nguyen AT, Salgado R, Mamidi A, Kim K, Diamond MS, Shresta S.

Nat Commun. 2018 Aug 2;9(1):3042. doi: 10.1038/s41467-018-05458-0.

38.

Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.

Frei JC, Wirchnianski AS, Govero J, Vergnolle O, Dowd KA, Pierson TC, Kielian M, Girvin ME, Diamond MS, Lai JR.

J Virol. 2018 Aug 29;92(18). pii: e01023-18. doi: 10.1128/JVI.01023-18. Print 2018 Sep 15.

39.

Mxra8 is a receptor for multiple arthritogenic alphaviruses.

Zhang R, Kim AS, Fox JM, Nair S, Basore K, Klimstra WB, Rimkunas R, Fong RH, Lin H, Poddar S, Crowe JE Jr, Doranz BJ, Fremont DH, Diamond MS.

Nature. 2018 May;557(7706):570-574. doi: 10.1038/s41586-018-0121-3. Epub 2018 May 16.

40.

Zika virus vaccines: immune response, current status, and future challenges.

Richner JM, Diamond MS.

Curr Opin Immunol. 2018 Aug;53:130-136. doi: 10.1016/j.coi.2018.04.024. Epub 2018 May 10. Review.

41.

An Immunocompetent Mouse Model of Zika Virus Infection.

Gorman MJ, Caine EA, Zaitsev K, Begley MC, Weger-Lucarelli J, Uccellini MB, Tripathi S, Morrison J, Yount BL, Dinnon KH 3rd, Rückert C, Young MC, Zhu Z, Robertson SJ, McNally KL, Ye J, Cao B, Mysorekar IU, Ebel GD, Baric RS, Best SM, Artyomov MN, Garcia-Sastre A, Diamond MS.

Cell Host Microbe. 2018 May 9;23(5):672-685.e6. doi: 10.1016/j.chom.2018.04.003.

42.

Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections.

Thackray LB, Handley SA, Gorman MJ, Poddar S, Bagadia P, Briseño CG, Theisen DJ, Tan Q, Hykes BL Jr, Lin H, Lucas TM, Desai C, Gordon JI, Murphy KM, Virgin HW, Diamond MS.

Cell Rep. 2018 Mar 27;22(13):3440-3453.e6. doi: 10.1016/j.celrep.2018.03.001.

43.

Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability.

Johnson B, VanBlargan LA, Xu W, White JP, Shan C, Shi PY, Zhang R, Adhikari J, Gross ML, Leung DW, Diamond MS, Amarasinghe GK.

Immunity. 2018 Mar 20;48(3):487-499.e5. doi: 10.1016/j.immuni.2018.01.014. Epub 2018 Mar 8.

44.

Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection.

Nair S, Huynh JP, Lampropoulou V, Loginicheva E, Esaulova E, Gounder AP, Boon ACM, Schwarzkopf EA, Bradstreet TR, Edelson BT, Artyomov MN, Stallings CL, Diamond MS.

J Exp Med. 2018 Apr 2;215(4):1035-1045. doi: 10.1084/jem.20180118. Epub 2018 Mar 6.

45.

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.

Fernandez E, Kose N, Edeling MA, Adhikari J, Sapparapu G, Lazarte SM, Nelson CA, Govero J, Gross ML, Fremont DH, Crowe JE Jr, Diamond MS.

MBio. 2018 Feb 27;9(1). pii: e00008-18. doi: 10.1128/mBio.00008-18.

46.

Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice.

Platt DJ, Smith AM, Arora N, Diamond MS, Coyne CB, Miner JJ.

Sci Transl Med. 2018 Jan 31;10(426). pii: eaao7090. doi: 10.1126/scitranslmed.aao7090.

47.

Structural Study of the C-Terminal Domain of Nonstructural Protein 1 from Japanese Encephalitis Virus.

Poonsiri T, Wright GSA, Diamond MS, Turtle L, Solomon T, Antonyuk SV.

J Virol. 2018 Mar 14;92(7). pii: e01868-17. doi: 10.1128/JVI.01868-17. Print 2018 Apr 1.

48.

Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice.

Scott JM, Lebratti TJ, Richner JM, Jiang X, Fernandez E, Zhao H, Fremont DH, Diamond MS, Shin H.

J Virol. 2018 Mar 14;92(7). pii: e00038-18. doi: 10.1128/JVI.00038-18. Print 2018 Apr 1.

49.

Vaccines in 2017: Closing in on a Zika virus vaccine.

Diamond MS, Coyne CB.

Nat Rev Immunol. 2018 Feb;18(2):89-90. doi: 10.1038/nri.2017.132. Epub 2017 Dec 4. Review. No abstract available.

PMID:
29199280
50.

Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization.

Giordano D, Draves KE, Young LB, Roe K, Bryan MA, Dresch C, Richner JM, Diamond MS, Gale M Jr, Clark EA.

PLoS Pathog. 2017 Nov 27;13(11):e1006743. doi: 10.1371/journal.ppat.1006743. eCollection 2017 Nov.

Supplemental Content

Loading ...
Support Center